Glatiramer acetate versus interferon Beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients

Author： Castelli-Haley Jane  

Publisher： Springer Publishing Company

ISSN： 0741-238X

Source： Advances in Therapy, Vol.25, Iss.8, 2008-08, pp. : 830-830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis

By  

International Archives of Allergy and Immunology, Vol. 165, Iss. 4, 2015-01 ,pp. : 244-246

Karger

Access to resources Recommend Favorite

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis

By Bergvall Niklas   Makin Charles   Lahoz Raquel   Agashivala Neetu   Pradhan Ashish   Capkun Gorana   Petrilla Allison   Karkare Swapna U.   Balderston McGuiness Catherine   Korn Jonathan R.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1647-1656

Informa Healthcare

Access to resources Recommend Favorite

Interferon beta‐1b‐induced Sweet's syndrome in a patient with multiple sclerosis

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 4, 2015-04 ,pp. : 456-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibodies to Commercially Available Interferon–Beta Molecules in Multiple Sclerosis Patients Treated with Natural Interferon–Beta

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 368-371

Karger

Access to resources Recommend Favorite

Meralgia paresthetica after subcutaneous injection of glatiramer acetate

By  

MUSCLE AND NERVE, Vol. 52, Iss. 1, 2015-07 ,pp. : 150-151

John Wiley & Sons Inc

Access to resources Recommend Favorite